Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech in the second half of 2024.
CEO/ C-suite/ Board
Job type: Permanent, Full-time
Location: Oxford
Right to work: Sponsorship available
Cancer Research Horizons, the innovation arm of Cancer Research UK, is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme.
Cambridge, UK: o2h discovery is pleased to announce the launch of o2h Biology Match Funding award, a unique programme aimed at accelerating drug discovery research by offering to match fund 50% of the cost for biology research projects up to $65K/£50K in value. This initiative presents an exciting opportunity for biotechs of all sizes and pharma to achieve key scientific milestones, helping to advance their drug discovery programmes.
by Tony Jones, CEO, One Nucleus
03 December 2024, London - A message from Dr Rich Ferrie – CEO, LBIC
LBIC is evolving. A lot has changed since we opened as London’s first bio-incubator over 24 years ago.
Today, we’re at a pivotal moment in our history, entering a new phase of growth as we expand into the Apex Building and continue to evolve within the dynamic life sciences landscape.
The successful candidate will play a key role in the establishment of a state-of-the-art electron microscopy (EM) connectomics laboratory at the MRC Laboratory of Molecular Biology (LMB). They will provide essential support in setting up and maintaining the laboratory, ensuring that all equipment, chemicals, and protocols are in place for smooth operation. Responsibilities will include coordinating the procurement and organisation of laboratory supplies, assisting with sample preparation, and supporting researchers in daily laboratory tasks.
As 2024 draws to a close, Biocair, an established global leader in life sciences logistics, renews its commitment to its customers and looks forward to another busy year in 2025. Welcoming a new CEO refreshed the company’s customer focus, driving its continued efforts to tackle complex logistics challenges.
London, December 3, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Curve Therapeutics (“Curve”) and is pleased to announce the placement of Rab Prinjha, PhD, as Chief Research and Development (R&D) Officer.
London, United Kingdom, 29th November 2024 / One Nucleus
The 24th Life Science networking conference, organised by membership organisation One Nucleus, will be hosted at the Royal Society of Medicine, on Wednesday 4th December.